Zusammenfassung
Antigene sind Substanzen, welche eine Immunantwort auslösen und mit den Immunzellen (T- und B-Lymphozyten) bzw. den von ihnen gebildeten Produkten (Antikörpern, s. Kapitel 7 „Autoantikörper bei rheumatischen Erkrankungen“) in spezifischer Weise interagieren. Immunantwort auslösende komplette Antigene werden auch als Immunogene bezeichnet. Inkomplette Antigene (Haptene) können allein keine Antwort induzieren, sondern wirken nur nach Kopplung mit bestimmten Trägermolekülen (Carrier) immunogen, reagieren dann aber mit den für sie spezifischen Antikörpern. Komplette Antigene können natürlicher, artifizieller oder synthetischer Herkunft sein (Tabelle 6.1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aikoh T, Tomokuni A, Matsukii T et al. (1998) Activation-induced cell death in human peripheral blood lymphocytes after stimulation with silieate in vitro. Int J Oncol 12: 1355–1359
Alarcon Segovia D, Cabral AR (2000) The anti-phospholipid antibody syndrome: clinical and serologieal aspects. Baillieres Best Pract Res Clin Rheumatol 14:139–150
Amoura Z, Piette JC, Bach JF, Koutouzov S (1999) The key role of nucleosomes in lupus. Arthritis Rheum 42:833–843
Anthony DD, Haqqi TM (1999) Collagen-induced arthritis in miee: an animal model to study the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 17:240–244
Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Hadey JB (2001) Development of anti-dsDNA autoantibodies prior to clinieal diagnosis of systemie lupus erythematosus. Scand J Immunol 54:211–219
Amett FC, Reveille JD, Goldstein R et al. (1996) Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetie, serologie, and clinieal analysis. Arthritis Rheum 39:1151–1160
Arribas J, Luz Rodriguez M, Alvarez Do Fomo R, Castano JG (1991) Autoantibodies against the multieatalytie proteinase in patients with systemie lupus erythematosus. J Exp Med 173:423–427
Asaga H, Yamada M, Senshu T (1998) Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem Biophys Res Commun 243:641–666
Astaldi Ricotti GC, Bestagno M, Cerino A et al. (1989) Antibodies to hnRNP core protein Al in connective tissue diseases. J Cell Biochem 40:43–47
Axford JS (1999) Glycosylation and rheumatic disease. Biochim Biophys Acta 1455:219–229
Bachmann M (2000) Somatic mutations, a mechanism for induction of autoimmunity. In: Conrad K, Humbel RL, Meurer M, Shoenfeld Y, Tan EM (eds) Autoantigens and autoantibodies: diagnostic tools and clues to understanding autoimmunity. Pabst Science Publishers, Lengerich, pp 187–241
Baeten D, Boots AM, Steenbakkers PG et al. (2000) Human cartilage gp-39+,CDl6+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 43:1233–1243
Barker RN, Wells AD, Ghoraishian M et al. (1996) Expression of mammalian 60-kD heat shock protein in the joints of mice with pristane-induced arthritis. Clin Exp Immunol 103:83–88
Benoist C, Mathis D (2000) A revival of the B cell paradigm for rheumatoid /arthritis pathogenesis? Arthritis Res 2:90–94
Billaut Mulot O, Cocude C, Kolesnitchenko V et al. (2001) SS-56, a novel cellular target of autoantibody responses in Sjogren syndrome and systemic lupus erythematosus. J Clin Invest 108:861–869
Bläß S, Union A, Raymackers J et al. (2001) The stress protein BiP is overexpressed and is a major Band T cell target in rheumatoid arthritis. Arthritis Rheum 44:761–771
Bockenstedt LK, Gee RJ, Mamula MJ (1995) Self-peptides in the initiation of lupus autoimmunity. J Immunol 154:3516–3524
Boire G, Gendron M, Monast N, Bastin B, Menard HA (1995) Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol 100:489–498
Borregaard N, Kjeldsen L, Lollike K, Sengelov H (1995) Granules and secretory vesicles of the human neutrophil. Clin Exp Immunol 101:16–19
Bouffard P, Laniel MA, Boire G (1996) Anti-Ro (SSA) antibodies: clinical significance and biological relevance. J Rheumatol 23:1838–1841
Bouffard P, Barbar E, Briere F, Boire G (2000) Interaction cloning and characterization of RoBPI, a novel protein binding to human Ro ribonucleoproteins. RNA 6:66–78
Brahms H, Raymackers J, Union A, Keyser F de, Meheus L, Luhrmann R (2000) The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies. J Biol Chem 275:17.122–17.129
Brockstedt E, Rickers A, Kostka S et al. (1998) Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein Al by caspase 3. J Biol Chem 273:28.057–28.064
Brouwer R, Hengstman GJ, Vree Egberts W et al. (2000) Autoantibody profIles in the sera of European patients with myositis. Ann Rheum Dis 60:116–123
Brouwer R, Pruijn GJ, Venrooij WJ van (2001) The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma. Arthritis Res 3:102–106
Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F (2000) Nucleosomes are major T and B cell auto antigens in systemic lupus erythematosus. Arthritis Rheum 43:2307–2315
Bui N, Strub K (1999) New insights into signal recognition and elongation arrest activities of the signal recognition particle. Biol Chem 380:135–145
Bunn CC, Denton CP, Shi Wen X, Knight C, Black CM (1998) Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol 37:15–20
Burd CG, Dreyfuss G (1994) Conserved structures and diversity of functions of RNA-binding proteins. Science 265:615–621
Buyon JP (1994) Neonatal lupus syndromes. Curr Opin Rheumatol 6:523–529
Buyon JP, Tseng CE, Di Donato F, Rashbaum W, Morris A, Chan EK (1997) Cardiac expression of 52beta, an alternative transcript of the congenital heart block-associated 52-kd SS-A/Ro auto antigen, is maximal during fetal development. Arthritis Rheum 40:655–660
Buyon JP, Kim MY, Copel JA, Friedman DM (2001) Anti-Ro/ SSA antibodies and congenital heart block: necessary but not sufficient. Arthritis Rheum 44:1723–1727
Casciola Rosen L, Rosen A (1997) Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus 6:175–180
Casciola Rosen LA, Miller DK, Anhalt GJ, Rosen A (1994) Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 269:30.757–30.760
Casciola Rosen L, Wigley F, Rosen A (1997) Scleroderma auto antigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 185:71–79
Casiano CA, Ochs RL, Tan EM (1998) Distinct cleavage products of nuclear pro teins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ 5:183–190
Casiano CA, Wu X, Molinaro C (2000) Apoptosis, necrosis and the genesis of autoantibodies: an integral overview. In: Conrad K, Humbel RL, Meurer M, Shoenfeld Y, Tan EM (eds) Autoantigens and autoantibodies: diagnostic tools and clues to understanding autoimmunity. Pabst Science Publishers, Lengerich, pp 152–186
Chabre H, Amoura Z, Piette JC, Godeau P, Bach JF, Koutouzov S (1995) Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 38:1485–1491
Cheng ST, Nguyen TQ, Yang YS, Capra JD, Sontheimer RD (1996) Calreticulin binds hYRNA and the 52-kDa polypeptide component of the Ro/SS-A ribonucleoprotein auto antigen. J Immunol 156:4484–4491
Chen X, Quinn AM, Wolin SL (2000) Ro ribonucleoproteins contribute to the resistance of Deinococcus radiodurans to ultraviolet irradiation. Genes Dev 14:777–782
Chiang SY, Swenberg JA, Weisman WH, Skopek TR (1997) Mutagenicity of vinyl chloride and its reactive metabolites, chloroethylene oxide and chloroacetaldehyde, in a metabolically competent human B-lymphoblastoid line. Carcinogenesis 18:31–36
Chindalore V, Neas B, Reichlin M (1998) The association between anti-ribosomal Pantibodies and active nephritis in systemic lupus erythematosus. Clin Immunol Immunopathol 87:292–296
Cohen IR (2001) Antigenic mlmlcry, clonal selection and autoimmunity. J Autoimmun 16:337–340
Conrad K, Mehlhorn J (2000) Diagnostic and prognostic relevance of autoantibodies in uranium miners. Int Arch Allergy Immunol 123:77–91
Conroy SE, Faulds GB, Williams W, Latchman DS, Isenberg DA (1994) Detection of autoantibodies to the 90 kDa heat shock protein in systemic lupus erythematosus and other autoimmune diseases. Br J Rheumatol 33:923–926
Cook AD, Rowley MJ, Mackay IR, Gough A, Emery P (1996) Antibodies to type 11 collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum 39:1720–1727
Cooley HM, Melny BJ, Gleeson R, Greco T, Kay TW (1999) Clinical and serological assoeiations of anti-Ku antibody. J Rheumatol 26:563–567
Cope AP, Sonderstrup G (1998) Evaluating candidate autoantigens in rheumatoid arthritis. Springer Semin Immunopathol 20:23–39
Corrigall VM, Bodman Smith MD, Fife MS et al. (2001) The human endoplasmic reticulum molecular chaperone BiP is an auto antigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol 166: 1492–1498
Craft J, Fatenejad S (1997) Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum 40:1374–1382
Craig JM, Earnshaw WC, Vagnarelli P (1999) Mammalian centromeres: DNA sequence, protein composition, and role in cell cycle progression. Exp Cell Res 246:249–262
Cremer MA, Rosloniec EF, Kang AH (1998) The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med 76:275–288
Datta SK, Kaliyaperumal A, Mohan C, Desai Mehta A (1997) T helper cells driving pathogenic anti-DNA autoantibody production in lupus: nucleosomal epitopes and CD40 ligand signals. Lupus 6:333–336
De Graeff Meeder ER, Eden W van, Rijkers GT et al. (1995) Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest 95:934–940
De Wildt RM, Finnern R, Ouwehand WH, Griffiths AD, Venrooij WJ van, Hoet RM (1996) Characterization of human variable domain antibody fragments against the U1 RNA-assoeiated A protein, selected from a synthetic and patient-derived combinatorial V gene library. Eur J Immunol 26:629–639
De Wildt RM, Steenbakkers PG, Pennings AH, Hoogen FH van den, Venrooij WJ van, Hoet RM (1997) A new method for the analysis and production of monoclonal antibody fragments originating from single human B cells. J Immunol Methods 207:61–67
Decker P, Briand JP, Mureia G de, Pero RW, Isenberg DA, Muller S (1998) Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in auto immune rheumatic and bowel diseases. Arthritis Rheum 41:918–926
Decker P, Isenberg D, Muller S (2000) Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. J Biol Chem 275:9043–9046
Despres N, Boire G, Lopez Longo FJ, Menard HA (1994) The Sa system: a novel antigen-antibody system speeific for rheumatoid arthritis. J Rheumatol 21:1027–1033
Dick T, Mierau R, Sternfeld R, Weiner EM, Genth E (1995) Clinical relevance and HLA assoeiation of autoantibodies against the nucleolus organizer region (NOR-90). J Rheumatol 22:67–72
Dighiero G (1997) Natural autoantibodies, tolerance, and autoimmunity. Ann N Y Acad Sci 815:182–192
Dighiero G, Rose NR (1999) Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity. Immunol Today 20:423–428
Ditzel HJ, Masaki Y, Nielsen H, Farnaes L, Burton DR (2000) Cloning and expression of a novel human antibody-antigen pair assoeiated with Felty’s syndrome. Proc Natl Acad Sei USA 97:9234–9239
Dominguez M, Cacoub P, Gareia de la Torre I et al. (2001) Autoantibodies to receptor induced neoepitopes of fibrinolytic pro teins in rheumatic and vascular diseases. J Rheumatol 28:302–308
Dorner T, Hucko M, Mayet WJ, Trefzer U, Burmester GR, Hiepe F (1995) Enhanced membrane expression of the 52 kDa Ro(SS-A) and La(SS-B) antigens by human keratinocytes induced by TNF alpha. Ann Rheum Dis 54:904–909
Dreyfuss G, Matunis MJ, Pinol Roma S, Burd CG (1993) hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 62:289–321
Earnshaw WC, Tomkiel JE (1992) Centromere and kinetochore structure. Curr Opin Cell Biol 4:86–93
Eden W van, Zee R van der, Paul AG et al. (1998) Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol Today 19:303–307
Eden W van, Wendling U, Paul L, Prakken B, Kooten P van, Zee R van der (2000) Arthritis protective regulatory potential of self-heat shock protein cross-reactive T cells. Cell Stress Chaperones 5:452–457
Eenennaam H van, Jarrous N, Venrooij WJ van, Pruijn GJ (2000) Architecture and function of the human endonucleases RNAse P and RNAse MRP. IUBMB Life 49:265–272
Eftekhari P, Salle L, Lezoualc’h F et al. (2000) Anti-SSA/R052 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol 30:2782–2790
Eftekhari P, Roegel JC, Lezoualc’h F, Fischmeister R, Imbs JL, Hoebeke J (2001) Induction of neonatallupus in pups of mice immunized with synthetic peptides derived from amino acid sequences of the serotoninergic 5-HT4 receptor. Eur J Immunol 31:573–579
Elkon KB, Bonfa E, Weissbach H, Brot N (1994) Antiribosomal antibodies in SLE, infection, and following deliberate immunization. Adv Exp Med Biol 347:81–92
Fabini G, Rutjes SA, Zimmermann C, Pruijn GJ, Steiner G (2000) Analysis of the niolecular composition of Ro ribonucleoprotein complexes. Identification of novel Y RNAbinding proteins. Eur J Biochem 267:2778–2789
Fabini G, Raijmakers R, Hayer S, Fouraux MA, Pruijn GJ, Steiner G (2001) The heterogeneous nuclear ribonucleoproteins land K interact with a subset of the ro ribonucleoprotein-associated Y RNAs in vitro and in vivo. J Biol Chem 276:20.711–20.718
Feist E, Dorner T, Kuckelkorn U et al. (1996) Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus. J Exp Med 184:1313–1318
Feist E, Kuckelkorn U, Dorner T et al. (1999) Autoantibodies in primary Sjogren’s syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum 42:697–702
Feist E, Dorner T, Kuckelkorn U, Scheffler S, Burmester G, Kloetzel P (2000) Diagnostie importance of anti-proteasome antibodies. Int Arch Allergy Immunol 123:92–97
Fritzler MJ, Chan EKL (2000) Autoantibodies to endosomes and the Golgi complex. In: Conrad K, Humbel RL, Meurer M, Shoenfeld Y, Tan EM (eds) Autoantigens and autoantibodies: diagnostie tools and dues to understanding autoimmunity. Pabst Seience Publishers, Lengerieh, pp 339–361
Fritzler M, Rattner JB (2000) Autoantibodies to the mitotie apparatus: Biologieal breakthroughs, dinieal applieation, etiologieal complexity. In: Conrad K, Humbel RL, Meurer M, Shoenfeld Y, Tan EM (eds) Autoantigens and autoantibodies: diagnostie tools and dues to understanding autoimmunity. Pabst Seience Publishers, Lengerieh, pp 58–86
Furuta K, Hildebrandt B, Matsuoka S et al. (1998) Immunological characterization of heterochrornatin protein p25beta autoantibodies and relationship with centromere autoantibodies and pulmonary fibrosis in systemie sderoderma. J Mol Med 76:54–60
Gallucei S, Matzinger P (2001) Danger signals: SOS to the immune system. Curr Opin Immunol 13:114–119
Gause A, Berek C (2001) Role of B cells in the pathogenesis of rheumatoid arthritis: potential implieations for treatment. Biodrugs 15:73–79
Ge Q, Wu Y, James JA, Targoff IN (1996) Epitope analysis of the major reactive region of the 100-kd protein of PM-Sd auto antigen. Arthritis Rheum 39:1588–1595
Geld YM van der, Limburg PC, Kallenberg CG (2001) Proteinase 3, Wegener’s auto antigen: from gene to antigen. J Leukoc Biol 69:177–190
Genth E, Mierau R (1995) Diagnostische Bedeutung Sklerodermie-und Myositis-assoziierter Autoantikorper. Z Rheumatol 54:39–49
George J, Afek A, Gilburd B et al. (1998) Induction of early atherosderosis in LDL-receptor-defieient miee immunized with beta2-g1ycoprotein 1. Circulation 98: 1108–1115
Georgescu L, Mevorach D, Arnett FC, Reveille JD, Elkon KB (1997) Anti-P antibodies and neuropsychiatrie lupus erythematosus. Ann N Y Acad Sci 14:823:263–269
Gething MJ (1999) Role and regulation of the ER chaperone BiP. Semin Cell Dev Biol 10:465–472
Girbal Neuhauser E, Durieux JJ, Arnaud M et al. (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro )filaggrin by deimination of arginine residues. J Immunol 162:585–594
Goldbach Mansky R, Lee J, McCoy A et al. (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2:236–243
Gong H, Zolzer F, Recklinghausen G von, Havers W, Schweigerer L (2000) Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cyde arrest and apoptosis. Leukemia 14:826–829
Greidinger EL, Hoffman RW (2001) The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the UI-70 kd and B’/B proteins as predominant U1 RNP immunogens. Arthritis Rheum 44:368–375
Greidinger EL, Casciola Rosen L, Morris SM, Hoffman RW, Rosen A (2000) Autoantibody recognition of distinctly modified forms of the Ul-70-kd antigen is associated with different dinieal disease manifestations. Arthritis Rheum 43:881–888
Grodzieky T, Elkon KB (2000) Apoptosis in rheumatie diseases. Am J Med 108:73–82
Gross WL, Csernok E (1995) Immunodiagnostie and pathophysiologie aspects of antineutrophil cytoplasmie antibodies in vasculitis. Curr Opin Rheumatol 7:11–19
Guerassimov A, Zhang Y, Banerjee S et al. (1998) Autoimmunity to cartilage link protein in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 25:1480–1484
Guerassimov A, Zhang Y, Cartman A et al. (1999) Immune responses to cartilage link protein and the GI domain of proteoglycan aggrecan in patients with osteoarthritis [published erratum appears in Arthritis Rheum 1999 Jun;42(6):1303. Arthritis Rheum 42:527–533
Guldner HH, Netter HJ, Szostecki C, Jaeger E, Will H (1990) Human anti-p68 autoantibodies recognize a common epitope of Ul RNA containing small nudear ribonudeoprotein and influenza B virus. J Exp Med 171:819–829
Haaheim LR, Halse AK, Kvakestad R, Stern B, Normann O, Jonsson R (1996) Serum antibodies from patients with primary Sjogren’s syndrome and systemie lupus erythematosus recognize multiple epitopes on the La(SS-B) auto antigen resembling viral protein sequences. Scand J Immunol 43:115–121
Harley JB, James JA (1999) Epstein-Barr virus infection may be an environmental risk factor for systemie lupus erythematosus in children and teenagers. Arthritis Rheum 42:1782–1783
Harvey G, Black C, Maddison P, McHugh N (1997) Characterization of antinudeolar antibody reactivity in patients with systemie sderosis and their relatives. J Rheumatol 24:477–484
Harvey GR, Butts S, Rands AL, Patel Y, McHugh NJ (1999) Clinical and serological assoeiations with anti-RNA polymerase antibodies in systemie sderosis. Clin Exp Immunol 117:395–402
Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS (1993) Autoantibody to the nudear antigen RA33: a marker for early rheumatoid arthritis. Br J Rheumatol 32:199–203
Hassfeld W, Steiner G, Studnieka Benke A et al. (1995) Autoimmune response to the spliceosome. An immunologie link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus. Arthritis Rheum 38:777–785
Hasunuma Y, Matsuura E, Makita Z, Katahira T, Nishi S, Koike T (1997) Involvement of beta 2-glycoprotein land anticardiolipin antibodies in oxidatively modified lowdensity lipoprotein uptake by macrophages. Clin Exp Immunol 107:569–573
Hausmann S, Wucherpfennig KW (1997) Activation of autoreactive T cells by peptides from human pathogens. Curr Opin Immunol 9:831–838
Hayem G, De Bandt M, Palazzo E et al. (1999) Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis. Ann Rheum Dis 58:291–296
Hemmerieh P, Neu E, Macht M, Peter HH, Krawinkel U, Mikecz A von (1998) Correlation between chlamydial infection and auto immune response: molecular mimiery between RNA polymerase major sigma subunit from Chlamydia trachomatis and human L7. Eur J Immunol 28:3857–3866
Hiepe F (2000) The partide nature of intracellular autoantigens. In: Conrad K, Humbel RL, Meurer M, Shoenfeld Y, Tan EM (eds) Autoantigens and autoantibodies: Diagnostic tools and dues to understanding autoimmunity. Pabst Science Publishers, Lengerich, pp 26–38
Hoch SO (1994) The Sm antigens. In: Venrooij WJ van, Maini RN (eds) Manual of biological markers of disease, vol B. Kluwer Academic Publishers, Dordrecht Boston London, pp 2.4/1–2.4/23
Holmdahl R (1998) Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis. Curr Opin Immunol 10:710–717
Holmdahl R, Andersson EC, Andersen CB, Svejgaard A, Fugger L (1999) Transgenic mouse models of rheumatoid arthritis. Immunol Rev 169:161–173
Horvath L, Czirjak L, Fekete B et al. (2001) Levels of antibodies against Clq and 60 kDa family of heat shock proteins in the sera of patients with various auto immune diseases. Immunol Lett 75:103–109
Hueber W, Hassfeld W, Smolen JS, Steiner G (1999) Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis. Rheumatology Oxford 38:155–159
Hultman P, Enestrom S, Tudey SJ, Pollard KM (1994) Selective induction of anti-fibrillarin autoantibodies by silver nitrate in mice. Clin Exp Immunol 96:285–291
Hultman P, Hansson-Georgiadis H (1999) Methyl mercuryinduced autoimmunity in mice. Toxicol Appl Pharmacol 154:203–211
Ieko M, Ichikawa K, Triplett DA et al. (1999) Beta2-glycoprotein I is necessary to inhibit protein C activity by monodonal anticardiolipin antibodies. Arthritis Rheum 42:167–174
Ioannou Y, Sultan S, Isenberg DA (1999) Myositis ovedap syndromes. Curr Opin Rheumatol 11:468–474
Isenberg DA (1995) Humoral immunity and glycosylation abnormalities in rheumatoid arthritis. Clin Exp Rheumatol 13:12s17–20
Iyer R, Holian A (1997) Involvement of the ICE family of proteases in siliea-indueed apoptosis in human alveolar macrophages. Am J Physiol 273:L760–L767
Iyer R, Hamilton RF, Li L, Holian A (1996) Silica-induced apoptosis mediated via seavenger receptor in human alveolar macrophages. Toxicol Appl Pharmacol 141:84–92
James JA, Hadey JB (1998) B-cell epitope spreading in autoimmunity. Immunol Rev 16:185–200
James JA, Gross T, Scofield RH, Hadey JB (1995) Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B’-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 181:453–461
James JA, Kaufman KM, Farris AD et al. (1997) An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100:3019–3026
James JA, Hadey JB, Scofield RH (2001) Role of virus es in systemic lupus erythematosus and Sjogren syndrome. Curr Opin Rheumatol 13:370–376
Jefferis R (1995) Rheumatoid factors, B cells and immunoglobulin genes. Br Med Bull 51:312–331
Jefferis R, Lund J, Pound JD (1998) IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol Rev 16:359–376
Ji H, Korganow AS, Mangialaio S et al. (1999) Different modes of pathogenesis in T-cell-dependent autoimmunity: dues from two TCR transgenic systems. Immunol Rev 16:139–146
Kallenberg CG (1998) Autoantibodies to myeloperoxidase: dinical and pathophysiological significance. J Mol Med 76:682–687
Karwan RM (1998) Further characterization of human RNAse MRP/RNAse P and related autoantibodies. Mol Biol Rep 25:95–101
Keech CL, Gordon TP, McCluskey J (1996) The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity. J Immunol 157:3694–3699
Khan MF, Wu X, Ansari GA (2001) Anti-malondialdehyde antibodies in MRL+I+ mice treated with trichloroethene and dichloroacetyl chloride: possible role of lipid peroxidation in autoimmunity. Toxicol Appl Pharmacol 170:88–92
Kindas Mugge I, Steiner G, Smolen JS (1993) Similar frequency of autoantibodies against 70-kD dass heat-shock proteins in healthy subjects and systemic lupus erythematosus patients. Clin Exp Immunol 92:46–50
Kishore U, Reid KB (2000) Clq: structure, function, and receptors. Immunopharmacology 49:159–170
Klein Gunnewick JMT, Venrooij WJ van (1994) Autoantigens contained in the U1 small nudear ribonudeoprotein complex. In: Venrooij WJ van, Maini RN (eds) Manual of biological markers of disease, vol B. Kluwer Academic Publishers, Dordrecht Boston London, pp 3.1/1–20
Koike T (2000) Anticardiopilin antibody — specificity and pathogenesis. In: Conrad K, Humbel RL, Meurer M, Shoenfeld Y, Tan EM (eds) Autoantigens and autoantibodies: diagnostic tools and dues to understanding autoimmunity. Pabst Science Publishers, Lengerich, pp 383–396
Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87:811–822
Kramer A (1996) The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu Rev Biochem 65:367–409
Kreeic AM, Swanson MS (1999) hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 11:363–371
Kuwana M, Okano Y, Kaburaki J, Medsger TA, Wright TM (1999) Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polyrnerase complexes. Arthritis Rheum 42:275–284
Labbe JC, Hekimi S, Rokeach LA (1999) Assessing the function of the Ro ribonudeoprotein complex using Caenorhabditis elegans as a biological tool. Biochem Cell Biol 77:349–354
Labbe JC, Burgess J, Rokeach LA, Hekimi S (2001) ROP-1, an RNA quality-control pathway component, affects Caenorhabditis elegans dauer formation. Proc Natl Acad Sci USA 97:13.233–13.238
Lacroix-Desmazes S, Kaveri SV, Mouthon L et al. (1998) Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Irnmunol Methods 216:117–137
Lan MS, Madaren NK (1998) Cryptic epitope and autoimrnunity. Diabetes Metab Rev 14:333–334
Latchman DS, Isenberg DA (1994) The role of hsp90 in SLE. Autoimmunity 19:211–218
Lee B, Craft JE (1995) Molecular structure and function of auto antigens in systemic sc1erosis. Int Rev Immunol 12:129–144
Lockshin MD, Letendre CH (1992) Antiphospholipid antibody/ lupus anticoagulant workshop. Arthritis Rheum 35:1234–1237
Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden JR (2000) Role of apoptosis in autoimmunity. Apoptosis 5:443–449
Lu L, Kaliyaperumal A, Boumpas DT, Datta SK (1999) Major peptide autoepitopes for nuc1eosome-speeific T cells of human lupus. J Clin Invest 104:345–355
Luross JA, Williams NA (2001) The genetic and immunopathological pro ces ses underlying collagen-induced arthritis. Immunology 103:407–416
Macario AJ (1995) Heat-shock proteins and molecular chaperones: implications for pathogenesis, diagnostics, and therapeutics. Int J Clin Lab Res 25:59–70
Mageed RA, Borretzen M, Moyes SP, Thompson KM, Natvig JB (1997) Rheumatoid factor autoantibodies in health and disease. Ann N Y Acad Sci 5:815.296–815.311
Mahler M, Mierau R, Bluthner M (2000) Fine-speeifieity of the anti-CENP-A B-cell auto immune response. J Mol Med 78:460–467
Mallard K, Jones DB, Richmond J, McGill M, Foulis AK (1996) Expression of the human heat shock pro tein 60 in thyroid, pancreatic, hepatic and adrenal autoimmunity. J Autoimmun 9:89–96
Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E et al. (2001) The major synovial targets of the rheumatoid arthritis-speeific antifllaggrin autoantibodies are deiminated forms of the alpha-and beta-chains of fibrin. J Immunol 166
Matsumoto I, Staub A, Benoist C, Mathis D (1999) Arthritis provoked by linked T and Beeil recognition of a glycolytic enzyme. Science 286:1732–1735
Mavragani CP, Tzioufas AG, Moutsopoulos HM (2000) Sjogren’s syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects. Int Arch Allergy Immunol 123:46–57
McCluskey J, Farris AD, Keech CL et al. (1998) Determinant spreading: lessons from animal models and human disease. Immunol Rev 16:4209–4229
Menard HA, Lapointe E, Rochdi MD, Zhou ZJ (2000) Insights into rheumatoid arthritis derived from the Sa immune system. Arthritis Res 2:429–432
Meroni PL, Raschi E, Testoni C, Tincani A, Balestrieri G (2001) Antiphospholipid antibodies and the endothelium. Rheum Dis Clin North Am 27:587–602
Mevoraeh D, Zhou JL, Song X, Elkon KB (1998) Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188:387–392
Mimori T (1996) Structures targeted by the immune system in myositis. Curr Opin Rheumatol 8:521–527
Miranda Carus ME, Boutjdir M, Tseng CE, DiDonato F, Chan EK, Buyon JP (1998) Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model. J Immunol 161:5886–5892
Mocei S, Lafferty K, Howard M (2000) The role of auto antigens in autoimmune disease. Curr Opin Immunol 12:725–730
Mohan C, Datta SK (1995) Lupus: key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 77:209–220
Montecucco C, Caporali R, Cobianchi F, Biamonti G (1996) Identification of autoantibodies to the I protein of the heterogeneous nuc1ear ribonuc1eoprotein complex in patients with systemic sc1erosis. Arthritis Rheum 39:1669–1676
Morgan K (1990) What do anti-collagen antibodies mean? Ann Rheum Dis 49:62–65
Moseley P (2000) Stress proteins and the immune response. Immunopharmacology 48:299–302
Muhlen CA von, Tan EM (1995) Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24:323–358
Nagaraju K, Cox A, Caseiola-Rosen L, Rosen A (2001) Novel fragments of the Sjögren’s syndrome autoantigens alphafodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic Iymphocyte granule-induced cell death. Arthritis Rheum 44:2376–2386
Neugebauer KM, Merrill JT, Wener MH, Lahita RG, Roth MB (2000) SR proteins are autoantigens in patients with systemic lupus erythematosus. Importanee of phosphoepitopes. Arthritis Rheum 43: 1768–1778
Nietert PJ, Sutherland SE, Silver RM et al. (1998) Is occupational organic solvent exposure a risk factor for sc1eroderma? Arthritis Rheum 41:1111–1118
O’Brien CA, Wolin SL (1994) A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors. Genes Dev 8:2891–2903
Pierangeli SS, Gharavi AE, Harris EN (2000) Experimental thrombosis and antiphospholipid antibodies: new insights. J Autoimmun 15:241–247
Pockley AG, Bulmer J, Hanks BM, Wright BH (1999) Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral eirculation of normal individuals. Cell Stress Chaperones 4:29–35
Pollard KM, Pearson DL, Bluthner M, Tan EM (2000) Proteolytic c1eavage of a self-antigen following xenobiotic-induced cell death produces a fragment with novel immunogenic properties. J Immunol 165:2263–2270
Pommier Y (1998) Diversity of DNA topoisomerases land inhibitors. Biochimie 80:255–270
Pritzker LB, Joshi S, Gowan JJ, Harauz G, Moscarello MA (2000) Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its strueture and susceptibility to digestion by cathepsin D. Biochemistry 39:5374–5381
Prockop DJ, Kivirikko KI (1995) Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Bioehern 64:403–434
Pruijn GJM (2000) Autoantigens in the nuc1eolus of human cells. In: Conrad K, Humbel RL, Meurer M, Shoenfeld Y, Tan EM (eds) Autoantigens and autoantibodies: diagnostic tools and clues to understanding autoimmunity. Pabst Seience Publishers, Lengerich, pp 41–57
Pruijn GJ, Simons FH, Venrooij WJ van (1997) Intraeellular loealization and nucleoeytoplasmic transport of Ro RNP components. Eur J Cell Biol 74:123–132
Rattner JB, Rees J, Arnett FC, Reveille JD, Goldstein R, Fritzier MJ (1996) The centromere kinesin-like protein, CENP-E. An auto antigen in systemic sclerosis. Arthritis Rheum 39:1355–1361
Rattner JB, Rees J, Whitehead CM et al. (1997) High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clin Invest Med 20:308–319
Reichlin M, Van Venrooij WJ (1991) Autoantibodies to the URNP particles: relationship to clinical diagnosis and nephritis. Clin Exp Irnrnunol 83:286–290
Reichlin M, Wolfson Reichlin M (1999) Evidence for the participation of anti-ribosomal P antibodies in lupus nephritis. Arthritis Rheum 42:2728–2729
Riemekasten G, Marell J, Trebeljahr G et al. (1998) A novel epitope on the C-terminus of SmDI is recognized by the majority of sera from patients with systemic lupus erythematosus. J Clin Invest 102:754–763
Rose NR (1998) The role of infection in the pathogenesis of autoimmune disease. Semin Immunol 10:5–13
Rothfield N, Whitaker D, Bordwell B, Weiner E, Senecal JL, Earnshaw W (1987) Detection of anticentromere antibodies using cloned autoantigen CENP-B. Arthritis Rheum 30:1416–1419
Roux S, Seelig HP, Meyer O (1998) Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis. J Rheumatol 25:395–396
Rowley MJ, Cook AD, Mackay IR, Teuber SS, Gershwin ME (1996) Comparative epitope mapping of antibodies to collagen in women with silicone breast implants, systemic lupus erythematosus and rheumatoid arthritis. Curr Top Microbiol Immunol 210:307–316
Rubin RL (1999) Etiology and mechanisms of drug-induced lupus. Curr Opin Rheumatol 11:357–363
Rutjes SA, Vree Egberts WT, Jongen P, Van Den Hoogen F, Pruijn GJ, Van Venrooij WJ (1997) Anti-R052 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Irnrnunol 109:32–40
Rutjes SA, Utz PJ, Heijden A van der, Broekhuis C, Venrooij WJ van, Pruijn GJ (1999) The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis. Cell Death Differ 6:976–986
Sabbatini A, Bombardieri S, Migliorini P (1993) Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virusencoded nuclear antigen EBNA 1. Eur J Immunol 23:1146–1152
Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N (2000) Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191:423–434
Savici D, He B, Geist LJ, Monick MM, Hunninghake GW (1994) Silica increases tumor necrosis factor (TNF) production, in part, by upregulating the TNF promoter. Exp Lung Res 20:613–625
Schaller M, Burton DR, Ditzel HJ (2001) Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat Immunol 2:746–753
Schellekens GA, Jong BA de, Hoogen FH van den, Putte LB van de, Venrooij WJ van (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101:273–281
Schett G, Redlich K, Xu Q et al. (1998a) Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSFI) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and HSFI activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs. J Clin Invest 102:302–311
Schett G, Steiner G, Smolen JS (1998b) Nuclear antigen histone Hl is primarily involved in lupus erythematosus cell formation. Arthritis Rheum 41:1446–1455
Schwartz M, Cohen IR (2000) Autoimmunity can benefit self-maintenance. Immunol Today 21:265–268
Scofield RH, Farris AD, Horsfall AC, Harley JB (1999) Fine specificity of the auto immune response to the RolSSA and La/SSB ribonucleoproteins. Arthritis Rheum 42:199–209
Scott DL (2000) Prognostic factors in early rheumatoid arthritis. Rheumatology 12:4–9
Segelmark M, Westman K, Wieslander J (2000) How and why should we detect ANCA? Clin Exp Rheumatol 18:629–635
Selak S, Chan EK, Schoenroth L, Senecal JL, Fritzler MJ (1999) Early endosome antigen. 1: An autoantigen associated with neurological diseases. J Invest Med 47:311–318
Selak S, Woodman RC, Fritzler MJ (2000) Autoantibodies to early endosome antigen (EEAI) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA). Clin Exp Immunol 122:493–498
Sherer Y, Shoenfeld Y (2001) Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis. Curr Atheroscler Rep 3:328–333
Shingai R, Maeda T, Onishi S, Yamamoto Y (1995) Autoantibody against 70 kD heat shock protein in patients with autoimmune liver diseases. J Hepatol 23:382–390
Shoenfeld Y, Sherer Y, Harats D (2001) Artherosclerosis as an infectious, inflammatory and auto immune disease. Trends Immunol 22:293–295
Siegert CE, Daha MR (1998) Clq as antigen in humoral autoimmune responses. Immunobiology 199:295–302
Simon M, Girbal E, Sebbag M et al. (1993) The cytokeratin filament-aggregating protein filaggrin is the target of the so-called “antikeratin antibodies,” autoantibodies specific for rheumatoid arthritis. J Clin Invest 92:1387–1393
Skriner K, Sommergruber WH, Tremmel V et al. (1997) Anti-A2IRA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease. J Clin Invest 100:127–135
Slobbe RL, Pluk W, Venrooij WJ van, Pruijn GJ (1992) Roribonucleoprotein assembly in vitro. Identification of RNAprotein and protein-protein interactions. J Mol Biol 227:361–366
Smolen JS (1996) Autoantibodies in rheumatoid arthritis. In: Venrooij WJ van, Maini RN (eds) Manual of biological markers of disease, vol C. Kluwer Academic Publishers, Dordrecht Boston London, pp 1.111–18
Smolen JS, Steiner G (1998) Are autoantibodies active players or epiphenomena? Curr Opin Rheumatol 10:201–206
Spronk PE, Limburg PC, Kallenberg CG (1995) Serological markers of disease activity in systemic lupus erythematosus. Lupus 4:86–94
Steiner G, Hartmuth K, Skriner K et al. (1992) Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Invest 90:1061–1066
Steiner G, Skriner K, Smolen JS (1996) Autoantibodies to the AIB proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatie diseases. Int Arch Allergy Immunol 111:314–319
Stemmer C, Muller S (1996) Histone autoantibodies other than (H2A-H2B)-DNA autoantibodies. In: Peter JB, Shoenfeld Y (eds) Autoantibodies. Elsevier Science, Amsterdam, pp 373–384
Sugimoto K, Kuriyama K, Shibata A, Himeno M (1997) Characterization of internal DNA-binding and C-terminal dimerization domains of human centromere/kinetochore auto antigen CENP-C in vitro: role of DNA-binding and self-associating activities in kinetochore organization. Chromosome Res 5:132–141
Sugimoto K, Kuriyama K, Himeno M, Muro Y (1998) Epitope mapping of human centromere auto antigen centromere protein C (CENP-C); heterogeneity of anti-CENP-C response in rheumatie diseases. J Rheumatol 25:474–481
Suzuki N, Mihara S, Sakane T (1997) Development of pathogenie anti-DNA antibodies in patients with systemie lupus erythematosus. FASEB J 11:1033–1038
Takasaki Y, Kaneda K, Takeuchi K, Yano T, Hashimoto H (2000) Antibodies to PCNA and Ki-a linked set of autoimmune response associated with cellular function of target antigens. In: Conrad K, Humbel RL, Meurer M, Shoenfeld Y, Tan EM (eds) Autoantigens and autoantibodies: diagnostie tools and c1ues to understanding autoimmunity. Pabst Science Publishers, Lengerich, pp 88–109
Takasaki Y, Kogure T, Takeuchi K et al. (2001) Reactivity of anti-proliferating cell nuc1ear antigen (PCNA) murine monoc1onal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation. J Immunol 166:4780–4787
Takeda Y, Dynan WS (2001) Autoantibodies against DNA double-strand break repair proteins. Front Biosci 6:D1335–D1345
Tan EM, Chan EK (1993) Molecular biology of auto antigens and new insights into autoimmunity. Clin Invest 71:327–330
Targoff IN (1993) Humoral immunity in polymyositis/dermatomyositis. J Invest DermatoL 100:116s–123s
Targoff IN (2000) Update on myositis-specific and myositisassociated autoantibodies. Curr Opin Rheumatol 12:475–481
Tishler M, Shoenfeld Y (1996) Anti-heat-shock protein antibodies in rheumatie and autoimmune diseases. Semin Arthritis Rheum 26:558–563
Utz PJ, Hottelet M, Venrooij WJ van, Anderson P (1998) Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonuc1eoprotein (snRNP) auto antigen complex accompanies apoptotie cell death. J Exp Med 187:547–560
Van Bruggen MC, Kramers C, Berden JH (1996) Autoimmunity against nuc1eosomes and lupus nephritis. Ann Med Interne (Paris) 147:485–489
Vazquez Abad D, Rothfield NF (1995) Autoantibodies in systemic sc1erosis. Int Rev Immunol 12:145–157
Venrooij W van, Pruijn GJM (1995) Ribonuc1eoprotein complexes as autoantigens. Curr Opin Immunol 7:819–824
Venrooij WJ van, Pruijn GJ (2000) Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2:249–251
Verhasselt V, Goldman M (2001) From autoimmune responses to autoimmune disease: what is needed? J Autoimmun 16:327–330
Verheijen R (1994) DNA topoisomerase I. In: Venrooij WJ van, Maini RN (eds) Manual of biologieal markers of dis-ease, vol B. Kluwer Academie Publishers, Dordrecht Boston London, pp 5.113–5.1116
Verheijden GF, Rijnders AW, Bos E et al. (1997) Human cartilage glycoprotein-39 as a candidate auto antigen in rheumatoid arthritis. Arthritis Rheum 40:1115–1125
Wahren Herlenius M, Muller S, Isenberg D (1999) Analysis of B-cell epitopes of the Ro/SS-A autoantigen. Immunol Today 20:234–240
Walport MJ, Davies KA, Botto M (1998) Clq and systemie lupus erythematosus. Immunobiology 199:265–285
Wang J, Dong X, Stojanov L, Kimpel D, Satoh M, Reeves WH (1997) Human autoantibodies stabilize the quaternary structure of Ku antigen. Arthritis Rheum 40:1344–1353
Wang D, Buyon JP, Zhu W, Chan EK (1999) Defining a novel 75-kDa phosphoprotein associated with SS-A/Ro and identification of distinct human autoantibodies. J Clin Invest 104:1265–1275
Warburton PE, Cooke CA, Bourassa S et al. (1997) Immunolocalization of CENP-A suggests a distinct nuc1eosome structure at the inner kinetochore plate of active centromeres. Curr Biol 7:901–904
Watanabe T, Sato T, Uchiumi T, Arakawa M (1996) Neuropsychiatrie manifestations in patients with systemie lupus erythematosus: diagnostie and predietive value of longitudinal examination of anti-ribosomal P antibody. Lupus 5:178–183
Weighardt F, Biamonti G, Riva S (1996) The roles of heterogeneous nuc1ear ribonuc1eoproteins (hnRNP) in RNA metabolism. Bioessays 18:747–756
Weyand CM, Klimiuk PA, Goronzy JJ (1998) Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin Immunopathol 20:5–22
Whitehead CM, Fritzler MJ, Rattner JB (1998) The relationship of ASE-1 and NOR-90 in autoimmune sera. J Rheumatol 25:2126–2130
Will CL, Luhrmann R (2001) Spliceosomal UsnRNP biogenesis, structure and function. Curr Opin Cell Biol 13:290–301
Wolin SL, Matera AG (1999) The trials and travels of tRNA. Genes Dev 13:1–10
Wu R, Lefvert AK (1995) Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subc1ass, affinity and effect on the macrophage uptake of oxLDL. Clin Exp Immunol 102:174–180
Wu X, Molinaro C, Johnson N, Casiano CA (2001) Secondary necrosis is a source of proteolytieally modified forms of specific intracellular autoantigens: implications for systemie autoimmunity. Arthritis Rheum 44:2642–2652
Wucherpfennig KW (2001) Structural basis of molecular mimiery. J Autoimmun 16:293–302
Xiao GQ, Qu Y, Hu K, Boutjdir M (2001) Down-regulation of L-type calcium channel in pups born to 52 kDa SSAI Ro immunized rabbits. Faseb J 15:1539–1545
Xu W, Seiter K, Feldman E, Ahmed T, Chiao JW (1996) The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood 87:4502–4506
Xue D, Rubinson DA, Pannone BK, Yoo Q, Wolin SL (2000) U snRNP assembly in yeast involves the La protein. EMBO J 19:1650–1660
Youinou P, Serre G (1995) The antiperinuc1ear factor and antikeratin antibody systems. Int Arch Allergy Immunol 107:508–518
Zee R van der, Anderton SM, Prakken AB, Liesbeth Paul AG, van Eden W (1998) T cell responses to conserved bacterial heat-shock-protein epitopes induce resistance in experimental autoimmunity. Semin Immunol 10:35–41
Zhang Y, Guerassimov A, Leroux JY et al. (1998) Induction oE arthritis in BALB/c mice by cartilage link protein: involvement oE distinct regions recognized by T and B lymphocytes. Am J Pathol 153:1283–1291
Zimmerman R, Radhakrishnan J, Valeri A, Appel G (2001) Advances in the treatment oE lupus nephritis. Annu Rev Med 2001:5263–5278
Zugel U, Kaufmann SH (1999) Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 12:19–39
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Steiner, G., Conrad, K. (2003). Autoantigene. In: Ganten, D., Ruckpaul, K., Gay, S., Kalden, J.R. (eds) Molekularmedizinische Grundlagen von rheumatischen Erkrankungen. Molekulare Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55803-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-55803-0_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62855-9
Online ISBN: 978-3-642-55803-0
eBook Packages: Springer Book Archive